HKD 0.04
(2.33%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 90.83 Million CNY | -23.16% |
2022 | 118.2 Million CNY | -21.05% |
2021 | 149.72 Million CNY | 36.31% |
2020 | 109.84 Million CNY | -16.48% |
2019 | 131.51 Million CNY | 11.86% |
2018 | 117.56 Million CNY | -8.29% |
2017 | 128.19 Million CNY | -11.57% |
2016 | 144.96 Million CNY | -41.93% |
2015 | 249.63 Million CNY | 8.52% |
2014 | 230.03 Million CNY | 1.27% |
2013 | 227.13 Million CNY | -33.19% |
2012 | 339.95 Million CNY | 56.49% |
2011 | 217.24 Million CNY | -51.07% |
2010 | 443.97 Million CNY | -12.96% |
2009 | 510.1 Million CNY | 51.65% |
2008 | 336.36 Million CNY | -8.98% |
2007 | 369.55 Million CNY | 183.4% |
2006 | 130.4 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 84 Million CNY | 0.0% |
2023 Q2 | 81.39 Million CNY | 0.0% |
2023 FY | 90.83 Million CNY | -23.16% |
2023 Q4 | 90.83 Million CNY | 0.0% |
2022 Q4 | 118.2 Million CNY | 0.0% |
2022 FY | 118.2 Million CNY | -21.05% |
2022 Q2 | 83.52 Million CNY | 0.0% |
2021 Q2 | 87.95 Million CNY | 0.0% |
2021 Q4 | 149.72 Million CNY | 0.0% |
2021 FY | 149.72 Million CNY | 36.31% |
2020 FY | 109.84 Million CNY | -16.48% |
2020 Q2 | 113.14 Million CNY | 0.0% |
2020 Q4 | 109.84 Million CNY | 0.0% |
2019 Q2 | 112.49 Million CNY | 0.0% |
2019 FY | 131.51 Million CNY | 11.86% |
2019 Q4 | 131.51 Million CNY | 0.0% |
2018 FY | 117.56 Million CNY | -8.29% |
2018 Q2 | 135.97 Million CNY | 0.0% |
2018 Q4 | 117.56 Million CNY | 0.0% |
2017 Q4 | 128.19 Million CNY | 0.0% |
2017 Q2 | 137.5 Million CNY | 0.0% |
2017 FY | 128.19 Million CNY | -11.57% |
2016 Q4 | 144.96 Million CNY | 0.0% |
2016 Q2 | 155.34 Million CNY | 0.0% |
2016 FY | 144.96 Million CNY | -41.93% |
2015 Q2 | 221.38 Million CNY | 0.0% |
2015 Q4 | 249.63 Million CNY | 0.0% |
2015 FY | 249.63 Million CNY | 8.52% |
2014 Q2 | 237.52 Million CNY | 0.0% |
2014 FY | 230.03 Million CNY | 1.27% |
2014 Q4 | 230.03 Million CNY | 0.0% |
2013 Q2 | 242.35 Million CNY | 0.0% |
2013 Q4 | 227.13 Million CNY | 0.0% |
2013 FY | 227.13 Million CNY | -33.19% |
2012 FY | 339.95 Million CNY | 56.49% |
2012 Q4 | 339.95 Million CNY | 0.0% |
2012 Q2 | 200.09 Million CNY | 0.0% |
2011 Q2 | 215.03 Million CNY | 0.0% |
2011 Q4 | 217.24 Million CNY | 0.0% |
2011 FY | 217.24 Million CNY | -51.07% |
2010 Q4 | 443.97 Million CNY | 0.0% |
2010 Q2 | 548.34 Million CNY | 0.0% |
2010 FY | 443.97 Million CNY | -12.96% |
2009 Q4 | 510.1 Million CNY | 0.0% |
2009 FY | 510.1 Million CNY | 51.65% |
2008 FY | 336.36 Million CNY | -8.98% |
2007 FY | 369.55 Million CNY | 183.4% |
2006 FY | 130.4 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 308.05 Million HKD | 70.515% |
Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 91.46% |
China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | 16.746% |
Prosperous Future Holdings Limited | 177.1 Million HKD | 48.715% |
Huasheng International Holding Limited | 675.58 Million HKD | 86.555% |
Fourace Industries Group Holdings Limited | 61.8 Million HKD | -46.964% |
Evergreen Products Group Limited | 786.46 Million HKD | 88.451% |
EC Healthcare | 2.97 Billion HKD | 96.942% |
Ming Fai International Holdings Limited | 772.01 Million HKD | 88.235% |
Blue Moon Group Holdings Limited | 1.61 Billion HKD | 94.386% |
SuperRobotics Holdings Limited | 172.27 Million HKD | 47.275% |
Takbo Group Holdings Limited | 42.84 Million HKD | -111.979% |
Hyfusin Group Holdings Limited | 181.34 Million HKD | 49.913% |